Monday, 23 May, 2022
TopicUSFDA

Topic: USFDA

Covaxin to be evaluated as Covid-19 vaccine candidate in US as FDA lifts clinical hold

PTI -
As many as 110 countries have agreed to mutual recognition of Covid-19 vaccination certificates with India that includes vaccination using Covaxin.

US approves Alzheimer’s drug for first time in 20 yrs. What is it & why it is controversial

Simrin Sirur -
US FDA has approved Aduhelm drug, which proposes to work by chipping away at protein deposits in the brain that cause memory loss and other symptoms of Alzheimer’s.

Indian pharma firms Zydus, Alembic recall 2 drugs in US over ‘life-threatening’ consequences

Himani Chandna -
Zydus Cadila recalls injection for treatment of herpes infections over complaints of crystallisation in vials, Alembic Pharmaceuticals recalls its high BP drug due to labelling error.

US FDA panel recommends emergency approval of Moderna Covid vaccine

PTI -
FDA's committee at its meeting Thursday voted 20-0 with one abstention to recommend Emergency Use Authorization for the Moderna COVID-19 vaccine mRNA-1273.

US approves first at-home, over-the-counter Covid test, calls it ‘major milestone’

Emma Court -
Made by Australia-based Ellume, the single-use nasal swab test is small enough to fit in the palm of a hand and delivers results in 15 minutes.

US FDA approves Pfizer Covid vaccine for emergency use

Robert Langreth -
It’s still unclear whether the vaccine, which was cleared by UK health regulators last week, is effective at preventing Covid-19’s spread, according to the FDA staff report.

First at-home Covid test gets approval — what this means, its impact & if it’s good news

Bloomberg News -
USFDA Tuesday issued an emergency use authorisation to Lucira Health Inc.’s rapid-result Covid test, the first that can be used at home. Here's all you'd like to know about it.

USFDA approves first at-home test kit for detecting Covid

Jinshan Hong -
While some Covid tests allow people to to mail in samples collected at home, this is the first that can be fully self-administered & provides results at home in 30 minutes or less.

Eli Lilly’s Covid antibody drug gets emergency-use clearance by USFDA

Riley Griffin -
The clearance gives doctors an option for tackling the coronavirus in high-risk patients before they’re sick enough to require hospitalization.

‘Deep state’ FDA is taking a beating as review of Covid vaccine approaches

Anna Edney -
At a time when the FDA needs the public’s trust more than ever, the US agency has been dragged into the political fray in a series of compounding incidents.
12Page 1 of 2

On Camera

YourTurn

Opinion

Inflation made luxury cars even more expensive but sales remain in fast lane. See Mercedes

Kushan Mitra -
For years, the luxury car market in India was biased towards the entry-level. But today, cars below Rs 40 lakh account for the smallest fraction of sales.
Representational image

Doomscrolling—why you continue to surf ‘depressing’ news and what you can do about it

Illustration by Ramandeep Kaur

Quad has a sea of challenges. Navy can take cue from a Maratha admiral who sank English ships

Economy

World’s $300 trillion in debt. Here’s what it means for services like health, education

Victoria Masterson -
To meet debt payments, at least 100 countries will have to reduce spending on essential services, the IMF estimates.

Defence

File photo of a defence personnel armed with a SiG 716 rifle near the Line of Control | Photo: Snehesh Alex Philip | ThePrint

India to ink ‘repeat order’ deal for 73,000 SiG 716 rifles from the US

Snehesh Alex Philip -
In February 2019, 72,400 SiG 716 rifles of 7.62 x 51mm calibre were contracted from SIG Sauer Inc, USA, under government's 'Buy (Global) category', through fast track procedure.

National Interest

Mandir or Masjid? New surveys not needed, just acceptance of truth & move towards reconciliation

Shekhar Gupta -
That temples were destroyed and mosques built is undisputed history. The past can’t be changed, but we can’t deny the wrongs of the past either before we consider reconciliation.

Follow us

Copyright © 2022 Printline Media Pvt. Ltd. All rights reserved.

×